TRPA1 and granular corneal dystrophy type II: Recently, in an oxazolone-induced murine model of ACD, the topical application of tacrolimus induced a persistent up-regulation of TRPA1 in DRG neurons and contributed to development of itch, thus explaining the pruritus and stinging sensation produced by the drug in humans [98].